VivoSim Labs, INC. VIVS
Biotechnology: Biological Products (No Diagnostic Substances) · data as of November 13, 2026
VivoSim Labs, INC. (VIVS) is a healthcare company listed in the US with a market value of about $3M. In the twelve months to September 30, 2026 it had revenue of $135000 and net income of -$10M, a net margin of -7605.9%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -109%.
About VivoSim Labs, INC.
VivoSim Labs, INC. is listed in the US and classified in biotechnology: biological products (no diagnostic substances). Revenue went from $571000 in 2015 to $131000 in 2026, a decline of about 12.5% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 256% over three years (dilution for shareholders). It spends 3198% of revenue on research and development.
Score: 0.6 / 5
Checks passed
- Strong R&D investment or growth above 20%
- ROE above 15%
- More cash than debt, or low debt to equity
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $135000 | $131000 | $144000 | $109000 | $370000 | $2M | $0 | $2M | $3M | $5M | $4M |
| Net income | -$10M | -$14M | -$2M | -$15M | -$17M | -$11M | -$17M | -$19M | -$27M | -$35M | -$38M |
| Free cash flow | -$10M | -$11M | -$9M | -$15M | -$13M | -$9M | -$14M | -$15M | -$20M | -$29M | -$31M |
| EPS (diluted) | $-0.44 | $-0.67 | $-0.21 | $-2.41 | $-2.97 | $-1.98 | $-3.66 | $-4.20 | $-6.90 | $-9.60 | $-11.70 |
| Net margin | -7605.9% | -10567.2% | -1727.8% | -13459.6% | -4664.6% | -763.2% | — | -852.0% | -861.7% | -756.1% | -908.9% |
| ROIC | — | — | -87.2% | -238.6% | -81.8% | -28.0% | -33.9% | -63.7% | -52.2% | -62.5% | -48.9% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does VivoSim Labs, INC. pay a dividend?
Not currently.
Is VivoSim Labs, INC. a good stock to buy?
We do not give buy or sell advice. VivoSim Labs, INC. scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.